Immunological Variables Associated to ICI Toxicity in Cancer Patients

Clinical trial NCT05429866 · UNKNOWN

Trial details

NCT number: NCT05429866
Sponsor: Jules Bordet Institute
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Cancer Melanoma Non Small Cell Lung Cancer Non-melanoma Skin Cancer Gastrointestinal Cancer Head and Neck Cancer Renal Cell Carcinoma Small Cell Lung Cancer Mesothelioma, Malignant Bladder Cancer Merkel Cell Carcinoma Hepatocellular Carcinoma

Start date: 2022-09-01
Primary completion: 2024-06-01
Enrollment: 441

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.